Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20179739rdf:typepubmed:Citationlld:pubmed
pubmed-article:20179739lifeskim:mentionsumls-concept:C0026769lld:lifeskim
pubmed-article:20179739lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:20179739lifeskim:mentionsumls-concept:C0021756lld:lifeskim
pubmed-article:20179739lifeskim:mentionsumls-concept:C1334114lld:lifeskim
pubmed-article:20179739lifeskim:mentionsumls-concept:C1334115lld:lifeskim
pubmed-article:20179739lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:20179739pubmed:issue7lld:pubmed
pubmed-article:20179739pubmed:dateCreated2010-6-17lld:pubmed
pubmed-article:20179739pubmed:abstractTextInterleukin (IL)-2/IL-2R signalling promotes proliferation and survival of activated T cells and has an essential non-redundant role in the production of regulatory T cells. Associations with different autoimmune diseases of polymorphisms in a linkage disequilibrium block in which the IL2/IL21 genes map (4q27), and also in genes encoding the IL2RA and IL2RB subunits (located in 10p15 and 22q13, respectively), were identified through genome-wide studies. Polymorphisms in these three genes were studied in 430 multiple sclerosis (MS) patients and in 550 ethnically matched controls from Madrid (Spain). Replication and meta-analysis with results from an independent cohort of 771 MS patients and 759 controls from Andalucía (Spain) confirmed the association of polymorphisms in the IL2RA gene (P(Mantel-Haenszel,) odds ratio (OR)(M-H) (95% confidence interval, CI) for rs2104286: 0.0001, 0.75 (0.65-0.87); for rs11594656/rs35285258: 0.004, 1.19 (1.06-1.34); for rs41295061: 0.03, 0.77 (0.60-0.98)); showed a trend for association of the IL2/IL21 rs6822844 (P(M-H)=0.07, OR(M-H) (95% CI)=0.86 (0.73-1.01)), but did not corroborate the association for IL2RB. Regression analyses of the combined Spanish cohort revealed the independence of two IL2RA association signals: rs2104286 and rs11594656/rs35285258. The relevant role of the IL2RA gene on MS susceptibility adds support to its common effect on autoimmune risk and the suggestive association of IL2/IL21 warrants further investigation.lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:languageenglld:pubmed
pubmed-article:20179739pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:citationSubsetIMlld:pubmed
pubmed-article:20179739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20179739pubmed:statusMEDLINElld:pubmed
pubmed-article:20179739pubmed:monthJullld:pubmed
pubmed-article:20179739pubmed:issn1476-5438lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:FernándezOsca...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:BartoloméManu...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:Fernández-Arq...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:de la...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:NúñezConcepci...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:UrcelayElenaElld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:ArroyoRafaelRlld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:de las...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:MatesanzFuenc...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:AlcinaAntonio...lld:pubmed
pubmed-article:20179739pubmed:authorpubmed-author:CavanillasMar...lld:pubmed
pubmed-article:20179739pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20179739pubmed:volume18lld:pubmed
pubmed-article:20179739pubmed:ownerNLMlld:pubmed
pubmed-article:20179739pubmed:authorsCompleteYlld:pubmed
pubmed-article:20179739pubmed:pagination794-9lld:pubmed
pubmed-article:20179739pubmed:dateRevised2011-8-1lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:meshHeadingpubmed-meshheading:20179739...lld:pubmed
pubmed-article:20179739pubmed:year2010lld:pubmed
pubmed-article:20179739pubmed:articleTitlePolymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.lld:pubmed
pubmed-article:20179739pubmed:affiliationImmunology Department, Hospital Clínico San Carlos, Madrid, Spain.lld:pubmed
pubmed-article:20179739pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20179739pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3558entrezgene:pubmedpubmed-article:20179739lld:entrezgene
entrez-gene:3559entrezgene:pubmedpubmed-article:20179739lld:entrezgene
entrez-gene:3560entrezgene:pubmedpubmed-article:20179739lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20179739lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20179739lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20179739lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20179739lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20179739lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20179739lld:entrezgene